1. Bioactive terpenoid constituents from Eclipta prostrata.
- Author
-
Yu SJ, Yu JH, Yu ZP, Yan X, Zhang JS, Sun JY, and Zhang H
- Subjects
- Anti-Bacterial Agents chemistry, Anti-Bacterial Agents isolation & purification, Bacillus subtilis drug effects, Cell Line, Tumor, Cell Proliferation drug effects, Drug Screening Assays, Antitumor, Glycoside Hydrolase Inhibitors chemistry, Glycoside Hydrolase Inhibitors isolation & purification, HeLa Cells, Humans, Microbial Sensitivity Tests, Neoplasms pathology, Phytochemicals chemistry, Phytochemicals isolation & purification, Plant Extracts chemistry, Plant Extracts isolation & purification, Staphylococcus aureus drug effects, Terpenes chemistry, Terpenes isolation & purification, alpha-Glucosidases metabolism, Anti-Bacterial Agents pharmacology, Eclipta chemistry, Glycoside Hydrolase Inhibitors pharmacology, Neoplasms drug therapy, Phytochemicals pharmacology, Plant Extracts pharmacology, Terpenes pharmacology
- Abstract
Chemical fractionation of the ethanolic extract of Eclipta prostrata yielded a series of unreported terpenoid constituents, including a rare 6/6/6/6-fused tetracyclic triterpenoid, a pentacyclic triterpenoid, two pentacyclic triterpenoid saponins, a diterpenoid and a sesquiterpenoid. Structures were assigned to these compounds on the basis of comprehensive spectroscopic analyses, with the absolute configurations of the tetracyclic triterpenoid, the diterpenoid and the sesquiterpenoid being determined via explanation of electronic circular dichroism data. Screening of these isolates in an array of bioassays revealed antibacterial, cytotoxic and α-glucosidase inhibitory activities for selective compounds. Of particular interest, the tetracyclic triterpenoid showed very strong inhibition against α-glucosidase with an IC
50 of 0.82 ± 0.18 μM, being 103 -fold as active as the positive control acarbose., (Copyright © 2019 Elsevier Ltd. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF